| SCHEDULE OF NET INCOME (LOSS) PER COMMON SHARE |
The
net income (loss) per common share amounts were determined as follows:
SCHEDULE OF NET INCOME (LOSS) PER COMMON SHARE
| | |
May
31, 2025 | | |
May
31, 2024 | |
| | |
For the Three Months Ended | |
| | |
May 31, 2025 | | |
May 31, 2024 | |
| Numerator: | |
| | | |
| | |
| Net income (loss) available to common shareholders | |
$ | (4,594,018 | ) | |
$ | (4,194,359 | ) |
| | |
| | | |
| | |
| | |
| | | |
| | |
| Effect of common stock equivalents | |
| | | |
| | |
| Less: dividends to C preferred shareholders | |
| (12,073 | ) | |
| — | |
| Net income (loss) adjusted for common stock equivalents | |
| (4,606,091 | ) | |
| (4,194,359 | ) |
| | |
| | | |
| | |
| Denominator: | |
| | | |
| | |
| Weighted average shares – basic | |
| 15,517,671,159 | | |
| 9,882,118,105 | |
| | |
| | | |
| | |
| Net income (loss) per share – basic | |
$ | (0.00 | ) | |
$ | (0.00 | ) |
| | |
| | | |
| | |
| Denominator: | |
| | | |
| | |
| Weighted average shares – diluted | |
| 15,517,671,159 | | |
| 9,882,118,105 | |
| | |
| | | |
| | |
| Net income (loss) per share – diluted | |
$ | (0.00 | ) | |
$ | (0.00 | ) |
|
The
net loss per common share amounts were determined as follows:
SCHEDULE
OF NET INCOME (LOSS) PER COMMON SHARE
| | |
February 28, | | |
February 29, | |
| | |
For the Year Ended | |
| | |
February 28, | | |
February 29, | |
| | |
2025 | | |
2024 | |
| Numerator: | |
| | | |
| | |
| Net loss available to common shareholders | |
$ | (18,935,592 | ) | |
$ | (20,708,716 | ) |
| | |
| | | |
| | |
| Effect of common stock equivalents | |
| | | |
| | |
| Less redemption dividend to Series F and Series B preferred shareholders | |
| (423,476 | ) | |
| — | |
| Net loss adjusted for common stock equivalents | |
| (19,358,968 | ) | |
| (20,708,716 | ) |
| | |
| | | |
| | |
| Denominator: | |
| | | |
| | |
| Weighted average shares - basic | |
| 11,647,673,315 | | |
| 7,080,914,317 | |
| | |
| | | |
| | |
| Net loss per share – basic | |
$ | (0.00 | ) | |
$ | (0.00 | ) |
| | |
| | | |
| | |
| Denominator: | |
| | | |
| | |
| Weighted average shares – diluted | |
| 11,647,673,315 | | |
| 7,080,914,317 | |
| | |
| | | |
| | |
| Net loss per share – diluted | |
$ | (0.00 | ) | |
$ | (0.00 | ) |
|
| SCHEDULE OF ANTI-DILUTIVE SHARES OF COMMON STOCK EQUIVALENTS |
The
anti-dilutive shares of common stock equivalents for the three months ended May 31, 2025 and 2024 were as follows:
SCHEDULE OF ANTI-DILUTIVE SHARES OF COMMON STOCK EQUIVALENTS
| | |
May
31, 2025 | | |
May
31, 2024* | |
| | |
For the Three Months Ended | |
| | |
May 31, 2025 | | |
May 31, 2024* | |
| Convertible Series F Preferred Shares | |
| 58,641,215,500 | | |
| 35,600,264,971 | |
| Convertible Redeemable Series B & C Preferred Shares | |
| 295,826,429 | | |
| 59,933,023 | |
| Stock options and warrants | |
| 226,177,522 | | |
| 486,251,667 | |
| Total | |
| 59,163,219,451 | | |
| 36,146,449,661 | |
|
The
anti-dilutive shares of common stock equivalents for the years ended February 28, 2025 and February 29, 2024 were as follows:
SCHEDULE
OF ANTI-DILUTIVE SHARES OF COMMON STOCK EQUIVALENTS
| | |
February 28, | | |
February 29, | |
| | |
For the Year Ended | |
| | |
February 28, | | |
February 29, | |
| | |
2025 | | |
2024 | |
| Convertible Class F Preferred Shares | |
| 49,722,965,500 | | |
| 31,873,690,805 | |
| Stock options and warrants | |
| 229,499,580 | | |
| 489,262,696 | |
| Total | |
| 49,952,465,080 | | |
| 32,362,953,501 | |
|